These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 26620305)

  • 1. Camellia sinensis Ameliorates the Efficacy of Last Line Antibiotics Against Carbapenem Resistant Escherichia coli.
    Thakur P; Chawla R; Chakotiya AS; Tanwar A; Goel R; Narula A; Arora R; Sharma RK
    Phytother Res; 2016 Feb; 30(2):314-22. PubMed ID: 26620305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmenting the potency of third-line antibiotics with Berberis aristata: In vitro synergistic activity against carbapenem-resistant Escherichia coli.
    Thakur P; Chawla R; Goel R; Narula A; Arora R; Sharma RK
    J Glob Antimicrob Resist; 2016 Sep; 6():10-16. PubMed ID: 27530832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of aquo-ethanolic extract of Camellia sinensis against Carbapenem Resistant Escherichia coli: In Vivo Trials in a Murine Model.
    Thakur P; Chawla R; Narula A; Goel R; Arora R; Sharma RK
    Biomed Pharmacother; 2016 Apr; 79():273-83. PubMed ID: 27044838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-hemolytic, hemagglutination inhibition and bacterial membrane disruptive properties of selected herbal extracts attenuate virulence of Carbapenem Resistant Escherichia coli.
    Thakur P; Chawla R; Narula A; Goel R; Arora R; Sharma RK
    Microb Pathog; 2016 Jun; 95():133-141. PubMed ID: 27057673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro bactericidal activity of Berberis aristata extract against clinical isolates of carbapenem-resistant Escherichia coli.
    Thakur P; Chawla R; Narula A; Goel R; Arora R; Sharma RK
    J Complement Integr Med; 2016 Sep; 13(3):229-237. PubMed ID: 27101558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of adhesion, quorum sensing and biofilm mediated virulence of carbapenem resistant Escherichia coli by selected natural plant products.
    Thakur P; Chawla R; Tanwar A; Chakotiya AS; Narula A; Goel R; Arora R; Sharma RK
    Microb Pathog; 2016 Mar; 92():76-85. PubMed ID: 26792674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
    Kuzucu C; Yetkin F; Görgeç S; Ersoy Y
    Mikrobiyol Bul; 2011 Jan; 45(1):28-35. PubMed ID: 21341156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.
    Pournaras S; Vrioni G; Neou E; Dendrinos J; Dimitroulia E; Poulou A; Tsakris A
    Int J Antimicrob Agents; 2011 Mar; 37(3):244-7. PubMed ID: 21236643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem regimen is related to meropenem MIC value.
    Oliva A; Scorzolini L; Cipolla A; Mascellino MT; Cancelli F; Castaldi D; D'Abramo A; D'Agostino C; Russo G; Ciardi MR; Mastroianni CM; Vullo V
    J Antimicrob Chemother; 2017 Jul; 72(7):1981-1984. PubMed ID: 28369424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
    Karaoglan I; Zer Y; Bosnak VK; Mete AO; Namiduru M
    J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual or Combined Effects of Meropenem, Imipenem, Sulbactam, Colistin, and Tigecycline on Biofilm-Embedded Acinetobacter baumannii and Biofilm Architecture.
    Wang YC; Kuo SC; Yang YS; Lee YT; Chiu CH; Chuang MF; Lin JC; Chang FY; Chen TL
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4670-6. PubMed ID: 27216052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bactericidal activities of meropenem and ertapenem against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a neutropenic mouse thigh model.
    DeRyke CA; Banevicius MA; Fan HW; Nicolau DP
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1481-6. PubMed ID: 17283197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activities of tigecycline alone and in combination with colistin sulfate or sulbactam against carbapenem-susceptible and -resistant Acinetobacter baumannii strains isolated from Intensive Care Units.
    Ozbek B; Otük G
    Int J Antimicrob Agents; 2010 Aug; 36(2):191-2. PubMed ID: 20537868
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro Efficacy of Meropenem, Colistin and Tigecycline Against the Extended Spectrum Beta-Lactamase Producing Gram Negative Bacilli.
    Gill MM; Usman J; Hassan A; Kaleem F; Anjum R
    J Coll Physicians Surg Pak; 2015 May; 25(5):342-5. PubMed ID: 26008659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro emergence of ertapenem resistance in Escherichia coli producing extended-spectrum β-lactamase].
    Villar HE; Jugo MB; Visser M; Hidalgo M; Hidalgo G; Maccallini GC
    Rev Esp Quimioter; 2014 Mar; 27(1):51-5. PubMed ID: 24676243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of succinic & oxalic acid in reducing the dosage of colistin against New Delhi metallo-β-lactamase-1 bacteria.
    Kumar R; Chandar B; Parani M
    Indian J Med Res; 2018 Jan; 147(1):97-101. PubMed ID: 29749367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic modeling of carbapenems and fluoroquinolones against bacteria that produce extended-spectrum beta-lactamases.
    Moczygemba LR; Frei CR; Burgess DS
    Clin Ther; 2004 Nov; 26(11):1800-7. PubMed ID: 15639692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model.
    Fan B; Guan J; Wang X; Cong Y
    PLoS One; 2016; 11(6):e0157757. PubMed ID: 27315107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro Activity of Colistin in Combination with Tigecycline against Carbapenem-Resistant Acinetobacter baumannii Strains Isolated from Patients with Ventilator-Associated Pneumonia.
    Cikman A; Gulhan B; Aydin M; Ceylan MR; Parlak M; Karakecili F; Karagoz A
    Int J Med Sci; 2015; 12(9):695-700. PubMed ID: 26392806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective antimicrobial activity of Cbf-K16 and Cbf-A7 A13 against NDM-1-carrying Escherichia coli by DNA binding after penetrating the cytoplasmic membrane in vitro.
    Hao Q; Wang H; Wang J; Dou J; Zhang M; Zhou W; Zhou C
    J Pept Sci; 2013 Mar; 19(3):173-80. PubMed ID: 23389882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.